首都医科大学学报 ›› 2010, Vol. 31 ›› Issue (5): 614-622.

• 基础研究 • 上一篇    下一篇

药物设计中的伪肽先导结构的发现

徐艳霞, 赵明, 王玉记, 吴建辉, 李莉, 张建伟, 康贵峰, 彭师奇*   

  1. 多肽及小分子药物北京市重点实验室, 首都医科大学化学生物学与药学院
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2010-10-21 发布日期:2010-10-21
  • 通讯作者: 彭师奇

Discovery of Lead Pseudopeptides for Drug Design

XU Yan-xia, ZHAO Ming, WANG Yu-ji, WU Jian-hui, LI Li, ZHANG Jian-wei, KANG Gui-feng, PENG Shi-qi*   

  1. Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, College of Pharmaceutical Sciences, Capital Medical University
  • Received:1900-01-01 Revised:1900-01-01 Online:2010-10-21 Published:2010-10-21
  • Contact: PENG Shi-qi

摘要:

先导化合物的发现是药物设计的关键步骤。伪肽是最重要的先导结构之一。或基于结构特征,或基于作用机制可以制备各种所需伪肽先导结构。过去几年在抗血栓、溶血栓、抗肿瘤、抗骨质疏松和排铅药物设计中,我们发表了大量生物碱-多肽、杂环-多肽、甾体-多肽和糖胺等伪肽先导结构。本文综述了多肽及小分子药物北京市重点实验室的一些伪肽先导结构的药理优势。

关键词: 伪肽, 药物设计, 抗血栓, 溶血栓, 抗肿瘤, 抗骨质疏松, 排铅

Abstract:

The discovery of lead compounds is a key step to drug design. Pseudopeptide is one of the most important lead structures. Various pseudopeptides could be prepared based on either the structures or the mechanisms of action. For the design of the anti-thrombotic, thrombolytic, anti-tumor, anti-osteoporosis and lead detoxification drugs, in the past years we published numerous reports on pseudopeptides of alkaloid-peptides, heterocyclics-peptides, steroid-peptides, saccharide-amino acids and so on. This paper reviews the pharmacological benefits of some pseudopeptides of our laboratory.

Key words: pseudopeptide, drug design, anti-thrombotic, thrombolytic, anti-tumor, anti-osteoporosis, lead detoxification

中图分类号: